3月19日A股投資避雷針︱大位科技:2024年淨虧損2213.2萬元;萬朗磁塑:股東金通安益擬減持不超4.00%股份
國光電氣股東國之光、天翊創投擬合計減持不超3%股份;萬朗磁塑股東金通安益擬減持不超4.00%股份;芳源股份股東五礦元鼎擬減持不超3%股份;大位科技2024年淨虧損2213.2萬元;新研股份2024年度淨虧損3.19億元;海洋王公司目前無“深海科技”相關業務和產品,與“深海科技”概念無關;康惠製藥除與恆昌醫藥在業務層面開展少量合作外,不存在借殼方面的相關合作;寧波東力目前機器人關節精密減速器尚處於研發階段;襄陽軸承暫無機器人軸承的市場應用;雙林股份滾柱絲槓產品僅完成相關樣品研發,尚未獲得定點或實現營業收入

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.